RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I <i>κ</i> B <i>α</i> /NF <i>κ</i> B and Enhancing Nrf2/HO‐1
- DOI
- 10.1155/omcl/9843608
- Published
- 2026-01
- Container
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1155/omcl/9843608,
title = {RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I
<i>κ</i>
B
<i>α</i>
/NF
<i>κ</i>
B and Enhancing Nrf2/HO‐1},
author = {Oxidative Medicine and Cellular Longevity},
year = {2026},
journal = {Oxidative Medicine and Cellular Longevity},
doi = {10.1155/omcl/9843608},
url = {https://doi.org/10.1155/omcl/9843608}
}RIS
TY - JOUR
TI - RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I
<i>κ</i>
B
<i>α</i>
/NF
<i>κ</i>
B and Enhancing Nrf2/HO‐1
AU - Oxidative Medicine and Cellular Longevity
PY - 2026
JO - Oxidative Medicine and Cellular Longevity
DO - 10.1155/omcl/9843608
UR - https://doi.org/10.1155/omcl/9843608
ER - APA
Longevity, O. M. A. C. (2026). RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I <i>κ</i> B <i>α</i> /NF <i>κ</i> B and Enhancing Nrf2/HO‐1. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/omcl/9843608
Source records
- crossref · retrieved 2026-11-11T00:37:27.982Z